To install click the Add extension button. That's it.

The source code for the WIKI 2 extension is being checked by specialists of the Mozilla Foundation, Google, and Apple. You could also do it yourself at any point in time.

How to transfigure the Wikipedia

Would you like Wikipedia to always look as professional and up-to-date? We have created a browser extension. It will enhance any encyclopedic page you visit with the magic of the WIKI 2 technology.

Try it — you can delete it anytime.

Install in 5 seconds
4,5
Kelly Slayton
Congratulations on this excellent venture… what a great idea!
Alexander Grigorievskiy
I use WIKI 2 every day and almost forgot how the original Wikipedia looks like.
Live Statistics
English Articles
Improved in 24 Hours
Added in 24 Hours
What we do. Every page goes through several hundred of perfecting techniques; in live mode. Quite the same Wikipedia. Just better.
Great Wikipedia has got greater.
.
Leo
Newton
Brights
Milds

Galunisertib

From Wikipedia, the free encyclopedia

Galunisertib
Clinical data
Routes of
administration		PO
Identifiers
  • 4-(5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-6-quinolinecarboxamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H19N5O
Molar mass369.428 g·mol−1
3D model (JSmol)
  • N1=CC=C(C2=CC(=CC=C12)C(=O)N)C1=C2N(N=C1C1C=CC=C(N=1)C)CCC2
  • InChI=1S/C22H19N5O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,23,28)
  • Key:IVRXNBXKWIJUQB-UHFFFAOYSA-N

Galunisertib (LY2157299) is a small molecular experimental cancer drug previously in development by Eli Lilly. It is a TGF-b inhibitor.[1] Development of galunisertib by Eli Lilly was discontinued in January 2020.[2]

Galunisertib was investigated in a phase II trial for treatment of hepatocellular carcinoma.[3] Pre-clinically, combination of galunisertib with PD-L1 blockade resulted in improved tumor growth inhibition.[4]

YouTube Encyclopedic

  • 1/1
    Views:
    469
  • Oncology Pharmacogenomics I: Solid Tumors 2010

Transcription

References

  1. ^ "Lilly Oncology Pipeline - Lilly USA". www.lillyoncologypipeline.com.
  2. ^ "Eli Lilly cuts 3 cancer drugs amid Q4 clear-out".
  3. ^ Clinical trial number NCT01246986 for "A Study of LY2157299 in Participants With Hepatocellular Carcinoma" at ClinicalTrials.gov
  4. ^ Holmgaard RB, Schaer DA, Li Y, Castaneda SP, Murphy MY, Xu X, Inigo I, Dobkin J, Manro JR, Iversen PW, Surguladze D, Hall GE, Novosiadly RD, Benhadji KA, Plowman GD, Kalos M, Driscoll KE (June 2018). "Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade". Journal for Immunotherapy of Cancer. 6 (1): 47. doi:10.1186/s40425-018-0356-4. PMC 5987416. PMID 29866156.
This page was last edited on 3 December 2023, at 18:40
Basis of this page is in Wikipedia. Text is available under the CC BY-SA 3.0 Unported License. Non-text media are available under their specified licenses. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. WIKI 2 is an independent company and has no affiliation with Wikimedia Foundation.
Contact WIKI 2
Introduction
Terms of Service
Privacy Policy